Skip to main content

Applications of CRISPR-Cas and genome editing techniques for established and emerging infectious diseases

Edited by 
Ben Berkhout, University of Amsterdam, Netherlands
Fatah Kashanchi, George Washington University, USA

New Content Item

The simplicity and broad applicability of targeted and programmable genome editing approaches, including but not limited to those based on CRISPR-Cas9, raise the possibility of a fundamentally new way to treat a variety of infections, as well as numerous therapeutic strategies for common diseases.

However, many challenges need overcoming before such techniques could be widely used in the clinic. Current issues of bottleneck in the field are complex; however, few stand out as particularly challenging. They include lack of optimized genome editors, specifically targeted delivery systems, reduced immunogenicity, improved or expanded cell-type targeting, simplification or increased scalability of production, transient or regulatable expression of genome editors, directed evolution, and selection methodologies to guide the identification of complexes with novel enzymatic activities, approaches to increase the frequency of HDR within target regions, while reducing non-specific events and substrate specificities and more predictive animal models and studies.

Through this series, jointly published in Retrovirology and Virology Journal, we are aiming to build a collection of articles that will highlight current developments in this area.

Submission instructions

Manuscripts should be formatted according to the individual journals instructions for authors and submitted via the online submission system. Before submitting your manuscript, please ensure you have carefully read the submission guidelines.

Retrovirology submission guidelines

Virology Journal submission guidelines

Submit here your complete manuscript to Retrovirology
Submit here your complete manuscript to Virology Journal

To ensure that you submit to the correct thematic series please select this thematic series in the drop-down menu upon submission.

Manuscripts will be peer-reviewed independently by the respective journal. Accepted articles will be published online on a continuous basis.

Pre-submission enquiries are welcome. If you have questions before submitting your manuscript, please contact the Editors-in-Chief.

Deadline for submissions: 31 July 2022

View all collections in Retrovirology.
View all collections in Virology Journal.

Back to Retrovirology homepage
Back to Virology Journal homepage

  1. Avian influenza (AI) is a disease caused by the avian influenza virus (AIV). These viruses spread naturally among wild aquatic birds worldwide and infect domestic poultry, other birds, and other animal species...

    Authors: Xu Zhou, Siwen Wang, Yue Ma, Yanbing Li, Guohua Deng, Jianzhong Shi and Xiurong Wang
    Citation: Virology Journal 2023 20:261
  2. Integrating CRISPR-Cas12a sensors with isothermal signal amplification can be exploited to develop low-cost, disposable, and ultrasensitive assays for the diagnostics of human pathogens.

    Authors: Weidong Qian, Jie Huang, Ting Wang, Cheng Fan, Jie Kang, Qian Zhang, Yongdong Li and Si Chen
    Citation: Virology Journal 2022 19:150
  3. Nonhuman primates (NHPs) are well-established basic and translational research models for human immunodeficiency virus (HIV) infections and pathophysiology, hematopoietic stem cell (HSC) transplantation, and a...

    Authors: Jenna Kropp Schmidt, Matthew R. Reynolds, Thaddeus G. Golos and Igor I. Slukvin
    Citation: Retrovirology 2022 19:17
  4. Programmable gene editing systems such as CRISPR-Cas have made mosquito genome engineering more practical and accessible, catalyzing the development of cutting-edge genetic methods of disease vector control. T...

    Authors: Micaela Finney, Joseph Romanowski and Zach N. Adelman
    Citation: Virology Journal 2022 19:128
  5. Despite antiretroviral treatment efficacy, it does not lead to the complete eradication of HIV infection. Consequently, reactivation of the virus from latently infected cell reservoirs is a major challenge tow...

    Authors: Lendel Correia da Costa, Larissa Maciel Bomfim, Uilla Victoria Torres Dittz, Camila de Almeida Velozo, Rodrigo Delvecchio da Cunha and Amilcar Tanuri
    Citation: Retrovirology 2022 19:12